Interestingly, in vivo study demonstrated that the mice-bearing tumor treated with both mTORi and connective tissue growth factor (CTGF)/E7 DNA vaccine had higher percentages of mature DCs in the TME with better disease control and prolonged survival. The gene discussed is CCN2; the disease is neoplasm.